BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 9384691)

  • 1. Recombinant adeno-associated virus (rAAV) vectors for somatic gene therapy: recent advances and potential clinical applications.
    Hallek M; Wendtner CM
    Cytokines Mol Ther; 1996 Jun; 2(2):69-79. PubMed ID: 9384691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant adeno-associated virus vectors.
    Hallek M; Girod A; Braun-Falco M; Wendtner CM; Bogedain C; Hörer M
    IDrugs; 1998 Sep; 1(5):561-73. PubMed ID: 18465596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant adeno-associated virus derived vectors (rAAV2) efficiently transduce ovarian and hepatocellular carcinoma cells--implications for cancer gene therapy.
    Małecki M; Swoboda P; Pachecka J
    Acta Pol Pharm; 2009; 66(1):93-9. PubMed ID: 19226976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.
    Conway JE; Rhys CM; Zolotukhin I; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
    Gene Ther; 1999 Jun; 6(6):986-93. PubMed ID: 10455400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adeno-associated virus as a gene therapy vector: vector development, production and clinical applications.
    Grieger JC; Samulski RJ
    Adv Biochem Eng Biotechnol; 2005; 99():119-45. PubMed ID: 16568890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical gene therapy using recombinant adeno-associated virus vectors.
    Mueller C; Flotte TR
    Gene Ther; 2008 Jun; 15(11):858-63. PubMed ID: 18418415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirus.
    Liu XL; Clark KR; Johnson PR
    Gene Ther; 1999 Feb; 6(2):293-9. PubMed ID: 10435114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene transfer by adeno-associated virus vectors into the central nervous system.
    Xiao X; Li J; McCown TJ; Samulski RJ
    Exp Neurol; 1997 Mar; 144(1):113-24. PubMed ID: 9126160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adeno-associated virus vectors for gene therapy of neurodegenerative disorders.
    During MJ; Leone P
    Clin Neurosci; 1995-1996; 3(5):292-300. PubMed ID: 8914796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia.
    High KA
    Trans Am Clin Climatol Assoc; 2003; 114():337-51; discussion 351-2. PubMed ID: 12813929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of recombinant adeno-associated virus for skeletal gene therapy.
    Dai J; Rabie AB
    Orthod Craniofac Res; 2007 Feb; 10(1):1-14. PubMed ID: 17284242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient gene transfer into human keratinocytes with recombinant adeno-associated virus vectors.
    Braun-Falco M; Doenecke A; Smola H; Hallek M
    Gene Ther; 1999 Mar; 6(3):432-41. PubMed ID: 10435093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AAV vectors: is clinical success on the horizon?
    Monahan PE; Samulski RJ
    Gene Ther; 2000 Jan; 7(1):24-30. PubMed ID: 10680012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical considerations of recombinant adeno-associated virus-mediated gene transfer for treatment of retinal degenerations.
    Shen WY; Lai CM; Lai YK; Zhang D; Zaknich T; Sutanto EN; Constable IJ; Rakoczy PE
    J Gene Med; 2003 Jul; 5(7):576-87. PubMed ID: 12825197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adeno-associated viral vectors for gene transfer and gene therapy.
    Büeler H
    Biol Chem; 1999 Jun; 380(6):613-22. PubMed ID: 10430026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orthopaedic gene therapy using recombinant adeno-associated virus vectors.
    Ke J; Zheng LW; Cheung LK
    Arch Oral Biol; 2011 Jul; 56(7):619-28. PubMed ID: 21354554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent developments in adeno-associated virus vector technology.
    Büning H; Perabo L; Coutelle O; Quadt-Humme S; Hallek M
    J Gene Med; 2008 Jul; 10(7):717-33. PubMed ID: 18452237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant AAV-mediated gene transfer to the retina: gene therapy perspectives.
    Rolling F
    Gene Ther; 2004 Oct; 11 Suppl 1():S26-32. PubMed ID: 15454954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stable rAAV-mediated transduction of rod and cone photoreceptors in the canine retina.
    Bainbridge JW; Mistry A; Schlichtenbrede FC; Smith A; Broderick C; De Alwis M; Georgiadis A; Taylor PM; Squires M; Sethi C; Charteris D; Thrasher AJ; Sargan D; Ali RR
    Gene Ther; 2003 Aug; 10(16):1336-44. PubMed ID: 12883530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.